The Potential Use of Mesenchymal Stem Cells and Their Derived Exosomes for Orthopedic Diseases Treatment
Authors:
- 24 June 2021
- journal article
- research article
- Published by Springer Nature in Stem Cell Reviews and Reports
- Vol. 18 (3) , 933-951
Abstract
Musculoskeletal disorders (MSDs) are conditions that can affect muscles, bones, and joints. These disorders are very painful and severely limit patients' mobility and are more common in the elderly. MSCs are multipotent stem cells isolated from embryonic (such as the umbilical cord) and mature sources (such as adipose tissue and bone marrow). These cells can differentiate into various cells such as osteoblasts, adipocytes, chondrocytes, NP-like cells, Etc. Due to MSC characteristics such as immunomodulatory properties, ability to migrate to the site of injury, recruitment of cells involved in repair, production of growth factors, and large amount production of extracellular vesicles, these cells have been used in many regenerative-related medicine studies. Also, MSCs produce different types of EVs, such as exosomes, to the extracellular environment. Exosomes reflect MSCs' characteristics and do not have cell therapy-associated problems because they are cell-free. These vesicles carry proteins, nucleic acids, and lipids to the host cell and change their function. This review focuses on MSCs and MSCs exosomes' role in repairing dense connective tissues such as tendons, cartilage, invertebrate disc, bone fracture, and osteoporosis treatment. Graphical abstractKeywords
Funding Information
- Tabriz University of Medical Sciences (67006)
This publication has 172 references indexed in Scilit:
- Targeting ER stress induced apoptosis and inflammation in cancerCancer Letters, 2013
- Mitochondrial dysfunction increases inflammatory responsiveness to cytokines in normal human chondrocytesArthritis & Rheumatism, 2012
- Mesenchymal stem cells: a double-edged sword in regulating immune responsesCell Death & Differentiation, 2012
- Osteoarthritis: A disease of the joint as an organArthritis & Rheumatism, 2012
- Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept studyThe Lancet Neurology, 2012
- Pannexin 1 channels mediate ‘find-me’ signal release and membrane permeability during apoptosisNature, 2010
- Bone-marrow-derived mesenchymal stem cells as a target for cytomegalovirus infection: Implications for hematopoiesis, self-renewal and differentiation potentialVirology, 2007
- Physiological roles for ecto-5’-nucleotidase (CD73)Purinergic Signalling, 2006
- Characterization of freshly isolated and cultured cells derived from the fatty and fluid portions of liposuction aspiratesJournal of Cellular Physiology, 2006
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006